Dany's BienenWohl


oxalic acid dihydrate

This medicine is authorised for use in the European Union.


Dany’s BienenWohl is a medicine used to treat varroosis in honey bee colonies. Varroosis is a disease of honey bees caused by infestation with a parasite called varroa mite (Varroa destructor). The varroa mite feeds on the haemolymph (blood) of adult bees and on brood (developing stages of the honey bee) resulting in harm and/or death of bees. The mite can also help spread viruses and bacteria. A significant mite infestation can lead to the collapse of a honey bee colony. Dany’s BienenWohl can only be used on colonies without brood and should be used as part of a wider management programme. If possible, the use of Dany’s BienenWohl should be alternated with another medicine that kills mites in a different way to reduce the chance of the mites developing resistance.


Dany’s BienenWohl contains the active substance oxalic acid. This medicine is the same as Oxybee, which is already authorised in the European Union (EU). The company that makes Oxybee has agreed that its scientific data can be used for Dany’s BienenWohl (‘informed consent’).

This EPAR was last updated on 17/07/2018

Authorisation details

Product details
Dany's BienenWohl
Agency product number
Active substance
oxalic acid dihydrate
International non-proprietary name (INN) or common name
oxalic acid dihydrate
Honey bees
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Dany Bienenwohl GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address
Geyerspergerstrasse 27
80689 Munich

Product information

14/06/2018 Dany's BienenWohl - EMEA/V/C/004667 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Ectoparasiticides for topical use, incl. insecticides

  • Ectoparaciticides, insecticides and repellents

Therapeutic indication

For the treatment of varroosis (Varroa destructor) of honey bees (Apis mellifera) in brood-free colonies.

Assessment history

How useful was this page?

Add your rating